WHO Health for All Report: Transforming Economies to Deliver Global Health Equity

What Is the WHO Health for All Report and Why It Matters

The WHO Council on the Economics of Health for All released its final report in 2023, presenting a landmark framework for redefining the relationship between economic systems and human health. Chaired by Professor Mariana Mazzucato, the Council brought together leading economists, health experts, and policymakers to address a fundamental question: why do the world’s economies consistently fail to deliver health and wellbeing for all people?

The report’s central argument is both radical and evidence-based — that health must cease to be treated as a cost centre or a mere input to economic productivity, and instead become a primary objective of economic policy itself. As WHO Director-General Dr Tedros Adhanom Ghebreyesus writes in the foreword: “Physical and mental wellbeing for all people must be a central goal of economies, not just a stepping stone to other objectives.”

This interactive analysis breaks down the report’s 13 recommendations, examines the economic data underpinning its conclusions, and explores the implications for governments, international institutions, and the private sector. For readers interested in how global institutions are addressing complex policy challenges through interactive content, this article provides both the substance and the analytical framework needed to understand what may be the most ambitious proposal for economic reform in global health history.

Health at the Centre of Economic Policy: The Core Thesis

The WHO Health for All report challenges the dominant economic paradigm that treats health spending primarily as consumption rather than investment. Professor Mazzucato’s preface articulates the shift clearly: “States can move from reactively fixing market failures to proactively and collaboratively shaping markets that prioritize human and planetary health.”

This market-shaping approach draws on decades of economic research demonstrating that the most successful innovations — from the internet to mRNA vaccines — emerged from active government investment and direction, not passive market correction. The Council argues that the same logic must apply to health systems: governments should set ambitious health missions and steer public and private investment toward achieving them.

The report identifies several critical failures in current economic thinking about health. First, national accounting systems like GDP fail to capture the value of health investments or the costs of health failures. Second, short-term budgetary thinking leads governments to view health spending as a liability rather than an asset that generates long-term economic returns. Third, international financial architecture systematically disadvantages low- and middle-income countries in their ability to invest in health infrastructure.

A key insight from the report is that “a healthy population is not just human and social capital, or a by-product of economic growth. Health is a fundamental human right.” This framing shifts the policy debate from efficiency arguments to justice arguments — requiring different metrics, different financing mechanisms, and different governance structures than those currently in place.

COVID-19 as the Ultimate Wake-Up Call for Health Systems

The WHO Health for All report dedicates substantial analysis to the COVID-19 pandemic as a case study in systemic health policy failure. The data is stark: COVID-19 pushed almost 100 million people into poverty in 2020, disproportionately affecting populations in low- and middle-income countries that had the least capacity to respond.

Perhaps the most damning statistic in the report concerns vaccine equity. Within a single year of vaccine rollout, 870 million excess doses had been hoarded by high-income countries — a situation the Council characterizes as “vaccine apartheid.” While wealthy nations secured multiple doses per capita, many African countries had vaccinated less than 5% of their populations by mid-2021.

The pandemic also exposed the critical importance of health workforce investment. Health workers — approximately 70% of whom are women — bore the brunt of the crisis on the frontlines. The report notes that there remains a huge global shortage of health workers, particularly in low-income settings, and that the gendered nature of the health workforce means pandemic responses disproportionately burden women.

Yet the report’s most powerful argument concerns the economics of prevention. World Bank and WHO estimates cited in the report indicate that building an effective global system of pandemic prevention and response would cost a mere US$1.30 per person on the planet. Compare this with the trillions of dollars in economic losses, the millions of deaths, and the devastating social disruption caused by COVID-19 — and the case for prevention-focused investment becomes overwhelming. Readers exploring how health policy research is transforming decision-making will find these cost-benefit analyses particularly compelling.

Interlinked Crises: How Health, Inequality and Climate Converge

One of the report’s most significant contributions is its analysis of the interconnection between health, socioeconomic inequality, and the climate crisis. Rather than treating these as separate policy domains, the WHO Council presents compelling evidence that they form a single, self-reinforcing system of crises that must be addressed together.

The climate-health nexus receives particularly detailed attention. The report cites that air pollution from burning fossil fuels is responsible for approximately 10.2 million premature deaths globally — making it one of the leading causes of death worldwide. Furthermore, climate change is projected to cause approximately 83 million excess deaths by the end of the century due to rising temperatures, extreme weather events, and the disruption of food and water systems.

The inequality dimension is equally stark. The report demonstrates that health outcomes are not simply a function of national wealth but of how that wealth is distributed and invested. Countries with similar GDP levels can have vastly different health outcomes depending on their investment in social determinants of health — housing, education, nutrition, clean water, and environmental protection.

The Council draws on the concept of planetary boundaries to argue that economic activity must operate within ecological limits. “Realizing the highest attainable standard for health starts not in the clinic or the hospital, but in homes, schools, streets and workplaces,” Dr Tedros notes — a statement that underscores the fundamentally cross-sectoral nature of health policy.

The Economics of Prevention: Why Inaction Costs Trillions

The WHO Health for All report builds an irrefutable economic case for prevention over reaction. The data on non-communicable diseases (NCDs) alone is staggering: the five leading causes of NCDs — cardiovascular disease, chronic respiratory disease, cancer, diabetes, and mental health conditions — are estimated to cost US$47 trillion between 2010 and 2030, averaging more than US$2 trillion per year.

Against this backdrop, the report highlights that an estimated US$140 billion investment to reduce global NCD deaths by one third could generate economic benefits of approximately US$2.7 trillion — a return on investment of nearly 20 to 1. This represents one of the most compelling cost-benefit ratios in global public policy.

The Council further documents the economic burden of antimicrobial resistance (AMR), which is expected to lead to roughly 10 million deaths annually by 2050 if not addressed through coordinated global action. The economic costs of AMR extend far beyond direct healthcare spending to include lost productivity, trade disruption, and the erosion of modern medicine’s ability to perform routine surgeries and treat infections.

These figures underscore the report’s central policy argument: that spending on health prevention, primary care, and social determinants is not a cost but an investment with measurable, substantial returns. The failure to make these investments — the “cost of inaction” — is orders of magnitude greater than the investment required.

Thirteen WHO Recommendations to Transform Health Financing

The heart of the WHO Health for All report is its 13 recommendations, organized under four strategic pillars. Each recommendation addresses a specific dimension of the systemic change needed to reorient economies toward health and wellbeing.

Pillar 1: Valuing Health for All

Recommendation 1 — Valuing the Essential: Treat health and wellbeing, health workers, and health systems as a long-term investment rather than a short-term cost. This requires fundamentally restructuring public and private accounting, budgeting, and investment analysis to reflect the long-term economic returns of health spending.

Recommendation 2 — Human Rights: Use legal and financial commitments to enforce health as a fundamental human right. This means embedding health rights in national constitutions and international law, backed by fiscal commitments that ensure accountability and adequate funding for universal health coverage.

Recommendation 3 — Planetary Health: Restore and protect the environment by upholding international commitments to a regenerative economy linking planetary and human health. This includes eliminating fossil fuel subsidies that harm public health and integrating climate targets into health policy frameworks.

Recommendation 4 — Dashboard for a Healthy Economy: Adopt multidimensional metrics — including health, wellbeing, equity, and environmental indicators — that track progress beyond the narrow, static measure of GDP.

Pillar 2: Financing Health for All

Recommendation 5 — Long-Term Finance: Create sustainable, predictable financing mechanisms for health at national and global levels, with emphasis on prevention, primary care, and workforce investment.

Recommendation 6 — Quality of Finance: Reform international financial rules, multilateral development bank policies, debt structures, and crisis response funds to provide fiscal space and access to capital for low- and middle-income countries.

Recommendation 7 — Funding and Governance of WHO: Ensure the World Health Organization is properly funded and governed to play its key global coordinating role in achieving Health for All — implying significant increases in assessed contributions and governance reform.

Pillar 3: Innovating for Health for All

Recommendation 8 — Collective Intelligence: Build symbiotic public-private alliances that maximize public value while sharing both risks and rewards of health innovation.

Recommendation 9 — Common Good: Redesign knowledge governance and intellectual property regimes to ensure global, equitable access to vital health innovations including vaccines, therapeutics, and diagnostics.

Recommendation 10 — Outcomes Orientation: Align innovation and industrial strategies with bold, cross-sectoral missions to deliver Health for All, using public procurement and mission-oriented policy to steer private sector innovation.

Pillar 4: Strengthening Public Sector Capacity

Recommendation 11 — Whole-of-Government: Recognize that Health for All is the responsibility of all government agencies — not just health ministries — including transport, housing, education, labour, and environment.

Recommendation 12 — State Capacity: Invest in the dynamic capabilities of the public sector, institutionalizing experimentation, learning, and rapid response to lead effectively in health mission management.

Recommendation 13 — Build Trust: Demonstrate transparency and meaningful public engagement to hold governments accountable for delivering the common good.

Reshaping Innovation and Intellectual Property for the Common Good

The WHO Health for All report’s innovation pillar addresses one of the most contentious issues in global health: how intellectual property and innovation governance should be structured to ensure equitable access to health technologies while maintaining incentives for research and development.

The Council’s analysis begins with the COVID-19 vaccine experience, where publicly funded research (including decades of government investment in mRNA technology) led to breakthrough vaccines that were then distributed according to market purchasing power rather than epidemiological need. The result — 870 million excess doses hoarded by wealthy nations — demonstrated that existing IP and distribution systems are fundamentally incompatible with equitable global health outcomes.

The report recommends building “symbiotic public-private alliances” that explicitly share both the risks and the rewards of health innovation. This means that when public investment contributes significantly to the development of a health technology, the public should retain meaningful rights over its pricing, manufacturing, and distribution — rather than transferring all commercial value to private actors.

Knowledge governance reform is equally critical. The Council calls for intellectual property regimes designed “for the common good,” including compulsory licensing provisions, technology transfer agreements, and open-science initiatives that accelerate equitable access. The report’s emphasis on the mRNA Vaccine Technology Transfer Programme as a case study demonstrates how these principles can work in practice.

Building Public Sector Capacity for Mission-Driven Health Policy

The final pillar of the WHO Health for All report may be its most ambitious: calling for a fundamental transformation in how governments organize themselves to deliver health outcomes. The Council argues that achieving Health for All requires not just more money or better policies, but a fundamentally more capable, dynamic, and accountable public sector.

The “whole-of-government” recommendation (Recommendation 11) addresses the institutional fragmentation that undermines health policy in most countries. When health outcomes are determined by housing conditions, air quality, food systems, education access, and working conditions, confining health policy to health ministries is structurally inadequate. The report calls for inter-ministerial coordination mechanisms that ensure every government department considers health impacts in its policy decisions.

Building state capacity (Recommendation 12) requires sustained investment in the skills, institutions, and processes that enable governments to manage complex, cross-sectoral missions. This includes strengthening regulatory agencies, improving public procurement, building data and analytics capabilities, and institutionalizing experimentation and learning within government organizations.

The trust dimension (Recommendation 13) recognizes that public sector legitimacy is essential to implementing ambitious health reforms. Governments must demonstrate transparency, create meaningful opportunities for public participation, and establish robust accountability mechanisms. Without public trust, even well-designed policies will face implementation resistance and political opposition. For those studying how policy documents are being reimagined through interactive formats, this governance framework provides essential context.

Measuring Progress Beyond GDP: Dashboards for a Healthy Economy

Recommendation 4 of the WHO Health for All report tackles the measurement challenge head-on: how do we know whether economies are actually delivering health and wellbeing? The answer, according to the Council, is that GDP alone is fundamentally inadequate as a measure of economic success.

The report advocates for “dashboards” that track progress across multiple dimensions of societal wellbeing — including health outcomes, health equity, environmental sustainability, social cohesion, and economic security. These metrics would complement GDP rather than replace it, providing policymakers with a more complete picture of whether their economies are serving human needs.

This approach builds on existing initiatives such as the OECD Better Life Index, Bhutan’s Gross National Happiness framework, and New Zealand’s Wellbeing Budget. The WHO Council’s contribution is to centre health explicitly within these alternative measurement frameworks and to provide specific guidance on which health indicators should be prioritized.

The practical implications are significant. When governments measure success by GDP growth alone, policies that increase economic output while worsening health outcomes — such as deregulating pollution or cutting social safety nets — can appear successful. Multidimensional dashboards would expose these trade-offs, creating political incentives for genuinely health-promoting economic policies. The shift to beyond-GDP metrics is not merely technical but fundamentally political — it changes what governments are held accountable for.

The mRNA Technology Transfer Programme: A Values-Driven Case Study

The WHO Health for All report includes the WHO mRNA Vaccine Technology Transfer Programme as a concrete example of how the report’s principles can be applied in practice. Launched in South Africa, the programme aimed to build manufacturing capacity for mRNA vaccines in low- and middle-income countries, reducing dependence on high-income country producers and addressing the structural inequities exposed during COVID-19.

The programme exemplifies several of the Council’s recommendations in action. It represents a mission-oriented public initiative (Recommendation 10) that uses technology transfer (Recommendation 9) to build local manufacturing capacity and state capability (Recommendation 12), while addressing equity in access to health innovation (Recommendation 8). The fact that it was coordinated by WHO demonstrates the organization’s potential role as a global health coordinator when adequately resourced (Recommendation 7).

However, the programme also illustrates the challenges identified in the report. Progress was slowed by IP barriers from originator companies, insufficient financing from the international community, and the complexities of technology transfer in a sector dominated by proprietary knowledge. These obstacles validate the Council’s call for systemic reform of IP regimes and international financing — incremental adjustments to existing systems were insufficient to achieve equitable access at the speed and scale required.

The case study serves as both proof of concept and cautionary tale: the principles of the Health for All report can work, but only if implemented alongside the structural reforms the Council recommends. Without those reforms, even well-intentioned programmes will face barriers that limit their impact and sustainability.